Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Debra Jeske Zack
David Isenberg

Lupus

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Lupus|March 29, 2008
Therapeutic potential (1)Debra Jeske Zack, David Isenberg
Lupus|May 26, 2023
A review of the development of gangrene in patients with systemic lupus erythematosus - A 44-year follow-up studyJoana Rua, David Isenberg
Lupus|January 21, 2021
Analysis of trends and causes of death in SLE patients over a 40-years period in a cohort of patients in the United KingdomAna Lorenzo-Vizcaya, David Isenberg
Lupus|March 29, 2008
Introduction to a systemic lupus erythematosus - biomarkers meeting held at University College London on 23rd and 24th February 2007David Isenberg, Michael Ehrenstein, Anisur Rahman
Lupus|May 6, 2026
Morbidity and mortality in primary versus secondary antiphospholipid syndrome: A single-center study using the 2023 ACR/EULAR criteriaRoni Meidan, Monica Angerri Nadal, Blanca Viejo Sosa, et al.
Lupus|July 18, 2023
Predictors of British Isles Lupus Assessment Group-based outcomes in patients with systemic lupus erythematosus: Analysis from the Systemic Lupus International Collaborating Clinics Inception CohortTrixy David, Li Su, Yafeng Cheng, et al.
Lupus|August 2, 2024
Comparison of clinical and serological features in thrombotic antiphospholipid syndrome patients, with and without associated systemic lupus erythematosus, followed for up to 42 years: A single centre retrospective studyPrabal Mittal, Marina Pacheco, Laura Trives-Folguera, et al.
Lupus|May 7, 2021
Anti-beta 2 glycoprotein I IgA in the SLICC classification criteria datasetMarwa Elkhalifa, Ana-Maria Orbai, Laurence S Magder, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Lupus|March 29, 2008
Therapeutic potential (1)Debra Jeske Zack, David Isenberg
Lupus|May 26, 2023
A review of the development of gangrene in patients with systemic lupus erythematosus - A 44-year follow-up studyJoana Rua, David Isenberg
Lupus|January 21, 2021
Analysis of trends and causes of death in SLE patients over a 40-years period in a cohort of patients in the United KingdomAna Lorenzo-Vizcaya, David Isenberg
Lupus|March 29, 2008
Introduction to a systemic lupus erythematosus - biomarkers meeting held at University College London on 23rd and 24th February 2007David Isenberg, Michael Ehrenstein, Anisur Rahman
Lupus|May 6, 2026
Morbidity and mortality in primary versus secondary antiphospholipid syndrome: A single-center study using the 2023 ACR/EULAR criteriaRoni Meidan, Monica Angerri Nadal, Blanca Viejo Sosa, et al.
Lupus|July 18, 2023
Predictors of British Isles Lupus Assessment Group-based outcomes in patients with systemic lupus erythematosus: Analysis from the Systemic Lupus International Collaborating Clinics Inception CohortTrixy David, Li Su, Yafeng Cheng, et al.
Lupus|August 2, 2024
Comparison of clinical and serological features in thrombotic antiphospholipid syndrome patients, with and without associated systemic lupus erythematosus, followed for up to 42 years: A single centre retrospective studyPrabal Mittal, Marina Pacheco, Laura Trives-Folguera, et al.
Lupus|May 7, 2021
Anti-beta 2 glycoprotein I IgA in the SLICC classification criteria datasetMarwa Elkhalifa, Ana-Maria Orbai, Laurence S Magder, et al.
Pageof 1